A pocket-size device under development could soon help monitor how well breast cancer treatments are working and help assess breast cancer risk by measuring levels of the hormone estrogen.

For postmenopausal women with breast cancer, treatment with the drug letrozole (Femara) increases survival after surgery more than the widely used tamoxifen, a new study confirms.